By Colleen Murphy | January 3, 2025
This action was surfaced by Law.com Radar, which delivers artificial intelligence-enhanced case summaries and daily case reports from more than 2,200 state and federal courts. Click here to get started and be among the first to act on opportunities in your region, practice area or client sector.
By Charles Toutant | January 2, 2025
The case pits an employee's right to religious expression against the company's support of its LGBTQ+ workers.
By Colleen Murphy | December 26, 2024
New Jersey-based pharmaceutical company UCB has sued to protect its patents for a Parkinson’s drug after an India-based company attempted to file an FDA application to create a generic version.
By Colleen Murphy | December 17, 2024
This complaint was first surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign up today and be among the first to know about new suits in your region, practice area or client sector.
By Charles Toutant | December 13, 2024
At least 29 patent suits were filed in the District of New Jersey in November, reflecting a jump from the rate of 18 suits per month in the period from December 2023 to November 2024. The multitude of suits include many that stem from generic drugmakers' plans to sell lower-priced versions of recognized pharmaceutical products.
By Mason Lawlor | December 2, 2024
An agreement between Hagens Berman and the plaintiff called for Walter L. Nixon, in-house counsel and chairman of the board of the Professional Drug Co., to receive 15% of attorney fees in return for serving as the lead plaintiff in litigation against Wyeth's prices for Effexor XR.
By Colleen Murphy | November 12, 2024
"The court finds Sandoz’s lost profits following the launch of generic treprostinil were a natural and probable consequence of United Therapeutics' breach of its promise," U.S. District Judge Brian Martinotti said.
By Colleen Murphy | November 11, 2024
“Since the contaminated products contained a defect that rendered them unusable, the products were worth less than their full purchase price,” Judge Cindy K. Chung said. “To hold otherwise would be to conclude that an unusable product is worth the same as a usable one—a conclusion that resists logic.”
By Emily Saul | October 1, 2024
U.S. District Judge Jesse Furman dismissed the action, finding that plaintiff was never properly appointed as successor-trustee and therefore was unable to bring the suit on behalf of shareholders.
By Colleen Murphy | September 23, 2024
The decision, which the U.S. Court of Appeals for the Third Circuit said was a "close call," hinged on whether an informal communication in the form of a letter the FDA sent to Merck was sufficient to establish preemption.
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
Gill & Chamas, LLC seeks a Personal Injury attorney to work in their Woodbridge, NJ office. Candidate must possess the following: ...
We are seeking an attorney with a minimum of four years of experience in transactional work to join our well-established, nationally renowne...